These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 18228200)
21. Ca(2+) -dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid β-treated astrocytes and in a model of Alzheimer's disease. Alberdi E; Wyssenbach A; Alberdi M; Sánchez-Gómez MV; Cavaliere F; Rodríguez JJ; Verkhratsky A; Matute C Aging Cell; 2013 Apr; 12(2):292-302. PubMed ID: 23409977 [TBL] [Abstract][Full Text] [Related]
22. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Mueller-Steiner S; Zhou Y; Arai H; Roberson ED; Sun B; Chen J; Wang X; Yu G; Esposito L; Mucke L; Gan L Neuron; 2006 Sep; 51(6):703-14. PubMed ID: 16982417 [TBL] [Abstract][Full Text] [Related]
23. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease. Hanzel CE; Pichet-Binette A; Pimentel LS; Iulita MF; Allard S; Ducatenzeiler A; Do Carmo S; Cuello AC Neurobiol Aging; 2014 Oct; 35(10):2249-62. PubMed ID: 24831823 [TBL] [Abstract][Full Text] [Related]
24. Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease. Watanabe N; Araki W; Chui DH; Makifuchi T; Ihara Y; Tabira T FASEB J; 2004 Jun; 18(9):1013-5. PubMed ID: 15084524 [TBL] [Abstract][Full Text] [Related]
25. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease. Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315 [TBL] [Abstract][Full Text] [Related]
26. Combined administration of D-galactose and aluminium induces Alzheimer-like lesions in brain. Xiao F; Li XG; Zhang XY; Hou JD; Lin LF; Gao Q; Luo HM Neurosci Bull; 2011 Jun; 27(3):143-55. PubMed ID: 21614097 [TBL] [Abstract][Full Text] [Related]
27. Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms. Herring A; Lewejohann L; Panzer AL; Donath A; Kröll O; Sachser N; Paulus W; Keyvani K Neurobiol Dis; 2011 Jun; 42(3):530-8. PubMed ID: 21406231 [TBL] [Abstract][Full Text] [Related]
28. Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. Kanekiyo T; Ban T; Aritake K; Huang ZL; Qu WM; Okazaki I; Mohri I; Murayama S; Ozono K; Taniike M; Goto Y; Urade Y Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6412-7. PubMed ID: 17404210 [TBL] [Abstract][Full Text] [Related]
29. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain. Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164 [TBL] [Abstract][Full Text] [Related]
30. The aluminium-amyloid cascade hypothesis and Alzheimer's disease. Exley C Subcell Biochem; 2005; 38():225-34. PubMed ID: 15709481 [TBL] [Abstract][Full Text] [Related]
31. Role of deferoxamine on enzymatic stress markers in an animal model of Alzheimer's disease after chronic aluminum exposure. Esparza JL; Garcia T; Gómez M; Nogués MR; Giralt M; Domingo JL Biol Trace Elem Res; 2011 Jun; 141(1-3):232-45. PubMed ID: 20455029 [TBL] [Abstract][Full Text] [Related]
38. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models. Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942 [TBL] [Abstract][Full Text] [Related]
39. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model. Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202 [TBL] [Abstract][Full Text] [Related]
40. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles. Chu J; Lauretti E; Craige CP; Praticò D J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]